MFX_multi_crystal_UV
August 29, 2024

Scientists unlock the secrets of how a key protein converts DNA into RNA

The results, which show how the protein adds nucleotides to the growing RNA chain, could lead to more effective medications.

By Ali Sundermier

Researchers at the Department of Energy’s SLAC National Accelerator Laboratory have uncovered new insights into the fundamental mechanisms of RNA polymerase II (Pol II), the protein responsible for transcribing DNA into RNA. Their study shows how the protein adds nucleotides to the growing RNA chain. The results, published in Proceedings of the National Academy of Sciences, have potential applications in drug development.

Pol II is found in all forms of life, from viruses to humans. Its role in gene expression, the process by which genetic information is used to synthesize proteins, makes it one of the most important proteins in the cell. Understanding the precise mechanism by which RNA polymerase adds nucleotides to RNA has been a longstanding challenge in the scientific community. Previous studies have provided only partial, low-resolution glimpses into this process.

One of the major challenges in studying Pol II has been the transient nature of the metals, particularly magnesium, within its active site. These metals play a crucial role in the chemical reactions that drive nucleotide addition, but their fleeting presence makes them difficult to observe. 

“The chemistry of the polymerase involves metals that are transient in the active site, making them hard to see,” said collaborator Guillermo Calero, a researcher and professor at the University of Pittsburgh. “This has been a significant obstacle in fully understanding the nucleotide addition process.”

To overcome these challenges, the research team used a novel crystallization technique that involved a special salt known for promoting protein-protein interactions. That technique allowed the researchers to capture the polymerase in a previously unseen state. This breakthrough allowed them to observe the “trigger loop,” a mobile part of Pol II that positions nucleotides in the active site, in unprecedented detail.

Calero_group
Guillermo Calero and his team working at the Macromolecular Femtosecond Crystallography end station at SLAC’s Linac Coherent Light Source (LCLS) during data collection.  (Aina Cohen/SLAC National Accelerator Laboratory)

The use of SLAC’s Linac Coherent Light Source (LCLS) X-ray laser was another key component of the study. It allowed the researchers to collect data before significant radation damage occurred to the sample, providing a clearer picture of the polymerase's structure and function. 

“For the first time, we were able to see the three magnesium ions in the active site,” said collaborator and SLAC scientist Aina Cohen. “This was only possible because of the free-electron laser data, which enabled us to see the extremely radiation-sensitive third metal ion.”

Another interesting finding emerged from studying a mutated version of Pol II. This mutant RNA polymerase operates faster than the wild type but also produces more errors.

"The mutation changes the structure of Pol II," said collaborator Craig Kaplan, a professor at the University of Pittsburgh. "Using LCLS, we can identify these structural changes, which could reveal how the mutation impacts Pol II’s activity."

The team is already working on time-resolved experiments to capture the real-time dynamics of the polymerase's trigger loop as it interacts with nucleotides with the hopes of unraveling the complexities of RNA polymerase function and contributing to the broader understanding of gene expression.

Further, by understanding the detailed mechanisms of human Pol II, researchers can now explore the development of molecules that could inhibit viral and bacterial polymerases while reducing harmful interactions with human polymerases. This is particularly relevant in the field of drug discovery, where the goal is to design drugs that are effective against pathogens but safe for human cells. 

“These structures not only advance our understanding of how human RNA polymerase functions, but they also provide a foundation to design more selective antiviral medications with less adverse side effects” Cohen said.

LCLS is a DOE Office of Science user facility. 

Citation: G. Lin et al., Proceedings of the National Academy of Sciences, 28 August 2024 (10.1073/pnas.2318527121)

For questions or comments, contact SLAC Strategic Communications & External Affairs at communications@slac.stanford.edu.


About SLAC

SLAC National Accelerator Laboratory explores how the universe works at the biggest, smallest and fastest scales and invents powerful tools used by researchers around the globe. As world leaders in ultrafast science and bold explorers of the physics of the universe, we forge new ground in understanding our origins and building a healthier and more sustainable future. Our discovery and innovation help develop new materials and chemical processes and open unprecedented views of the cosmos and life’s most delicate machinery. Building on more than 60 years of visionary research, we help shape the future by advancing areas such as quantum technology, scientific computing and the development of next-generation accelerators.

SLAC is operated by Stanford University for the U.S. Department of Energy’s Office of Science. The Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time.

Dig Deeper

Related stories

News Feature

Alimohamadi is being recognized for her novel integration of theoretical and experimental results to connect diverse health outcomes with cell membrane behavior.

Haleh Alimohamadi
News Brief

Wheat and other sources of gluten can spell trouble for people with the disease, but new findings could aid the development of first-ever drugs...

Close up of wheat in a field.
News Feature

Researchers figured out how to spray and freeze a cell sample in its natural state in milliseconds, helping them capture basic biological processes in...

These are two images of the same cell at different times during an experiment.
News Feature

Alimohamadi is being recognized for her novel integration of theoretical and experimental results to connect diverse health outcomes with cell membrane behavior.

Haleh Alimohamadi
News Brief

Wheat and other sources of gluten can spell trouble for people with the disease, but new findings could aid the development of first-ever drugs...

Close up of wheat in a field.
News Feature

Researchers figured out how to spray and freeze a cell sample in its natural state in milliseconds, helping them capture basic biological processes in...

These are two images of the same cell at different times during an experiment.
News Feature

Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer...

Three people in lab coats examine chemistry equipment.
News Feature

Disabling those hinges could be a good strategy for designing vaccines and treatments against a broad range of coronavirus infections.

A 3D image of a round, spiky coronavirus with inset showing how far its spikes can bend.
News Feature

A   swap of metals and a mutation ramp up the electric field strength at the active site of an enzyme, making it  ...

Illustration of an enzyme modified to work 50 times faster